Eric D Snyder, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 999 Washington Ave, Holland, MI 49423 Phone: 616-396-2316 Fax: 616-396-0085 |
John H Arendshorst, M.D. Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 999 Washington Ave, Holland, MI 49423 Phone: 616-396-2316 Fax: 616-396-0085 |
Peter Henry Bast, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 111 W 24th St, Holland, MI 49423 Phone: 616-396-0006 |
Dr. Lisa J. Vredevoogd, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 205 W 29th St, Suite 50, Holland, MI 49423 Phone: 616-796-9995 Fax: 616-796-9998 |
Dr. Benjamin David Currie, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 999 Washington Ave, Holland, MI 49423 Phone: 616-396-2316 Fax: 616-396-0085 |
Dr. Matthew Spencer Currie, M.D. Ophthalmology Medicare: Accepting Medicare Assignments Practice Location: 999 Washington Ave, Holland, MI 49423 Phone: 616-396-2316 Fax: 616-396-0085 |
Thomas R. Arendshorst, MD Ophthalmology Medicare: Not Enrolled in Medicare Practice Location: 336 S River Ave, Holland, MI 49423 Phone: 616-394-3788 |
News Archive
Twenty-five families who have overcome diabetes caused by a defect in a single gene will gather at "Celebrating the Miracles," a University of Chicago symposium for patients, parents and physicians. The first Monogenic Diabetes Forum is designed to review scientific studies, celebrate treatment successes, stress the importance of a genetic diagnosis for children diagnosed before age one, and exchange tips on how to make the most of a new concept-life without insulin injections.
A study led by researchers at Beth Israel Deaconess Medical Center, in collaboration with scientists at Walter Reed Army Institute of Research, Janssen Vaccines & Prevention B.V., one of the Janssen Pharmaceutical Companies of Johnson & Johnson and Gilead Sciences, Inc., has demonstrated that combining an experimental vaccine with an innate immune stimulant may help lead to viral remission in people living with HIV.
Two University of Houston researchers, working to find cancer cures, received grants from the Cancer Prevention & Research Institute of Texas, the organization that funds groundbreaking cancer research and prevention programs in the state.
A "game changing" new antibiotic which is capable of killing superbugs has been successfully synthesized and used to treat an infection for the first time - and could lead to the first new class of antibiotic drug in 30 years.
Solar cells, quantum computing and photodynamic cancer therapy. These all involve molecules switching between magnetic and nonmagnetic forms.
› Verified 9 days ago